NCT05615896

Brief Summary

The primary objective is to collect OCT scans on a modified P200TxE and P200TE.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2021

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2021

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2022

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

6 days

First QC Date

June 21, 2021

Last Update Submit

March 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Collection of images

    The primary endpoint will be the collection of OCT scans on the P200TE and P200TxE devices. The scans will be used by R\&D for development of a de-noising algorithm as well as other possible developments.

    1 year

Study Arms (2)

P200TxE Device First

EXPERIMENTAL
Device: Imaging Session

P200TE Device First

EXPERIMENTAL
Device: Imaging Session

Interventions

Various scans will be captured on both devices

P200TE Device FirstP200TxE Device First

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female volunteers 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
  • Volunteers who can follow the instructions by the clinical staff at the clinical site;
  • Volunteers who agree to participate;
  • Volunteers who have been diagnosed with retina pathology with intra-retinal and/or subretinal fluid present in the posterior pole region.

You may not qualify if:

  • Volunteers unable to tolerate ophthalmic imaging;
  • Volunteers with ocular media not sufficiently clear to obtain acceptable OCT images.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Retina Consultants of Texas Research Centers

Houston, Texas, 77401, United States

Location

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: A
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2021

First Posted

November 14, 2022

Study Start

April 22, 2021

Primary Completion

April 28, 2021

Study Completion

June 17, 2022

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations